EUVIMEDEUVIMED entdecken
Crossref

Early glucocorticoid withdrawal in severe ANCA ‐associated vasculitis treated with combination cyclophosphamide and rituximab: a single‐centre case series

Tania Salehi iD, Karthik Venkataraman iD, Jarrad Hopkins, John Lau iD, Philip Clayton, Joanna Tieu, Chen Au Peh

Internal Medicine Journal · 2025

DOI: 10.1111/imj.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Tania Salehi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Royal Adelaide Hospital, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Cyclophosphamide, Glucocorticoids, Immunosuppressive Agents. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid (GC)‐related toxicity remains a major challenge in anti‐neutrophil cytoplasm antibody‐associated vasculitis (AAV). We report five cases of newly diagnosed severe AAV treated with combination cyclophosphamide and rituximab, with the goal of ceasing GCs within 4 weeks. All patients achieved complete remission, with one relapse during follow‐up. All remained GC‐free at a median follow‐up of 12 months. The regimen was well tolerated despite severe renal impairment. These findings support the feasibility of early GC withdrawal in organ‐threatening AAV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisCyclophosphamideGlucocorticoidsImmunosuppressive AgentsRituximabAgedFemaleHumansMaleDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

ANCA vasculitiscyclophosphamideglucocorticoidsinduction treatmentrituximab

Substanzen

CyclophosphamideGlucocorticoidsImmunosuppressive AgentsRituximab

Autor:innen und Institutionen

  • Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • The University of Adelaide, Adelaide, South Australia, Australia.
  • School of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Rheumatology Department, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
  • Rheumatology Department, Northern Adelaide Local Health Network, Adelaide, South Australia, Australia.

ORCID-Profile: Tania Salehi, Karthik Venkataraman, John Lau

Zitieren

APA

Salehi, T., Venkataraman, K., Hopkins, J., Lau, J., Clayton, P., Tieu, J., & Peh, C. A. (2025). Early glucocorticoid withdrawal in severe ANCA ‐associated vasculitis treated with combination cyclophosphamide and rituximab: a single‐centre case series. Internal Medicine Journal. https://doi.org/10.1111/imj.70212

Vancouver

Salehi T, Venkataraman K, Hopkins J, Lau J, Clayton P, Tieu J, et al. Early glucocorticoid withdrawal in severe ANCA ‐associated vasculitis treated with combination cyclophosphamide and rituximab: a single‐centre case series. Internal Medicine Journal. 2025. doi:10.1111/imj.70212

BibTeX
@article{Salehi2025,
  author = {Salehi, Tania and Venkataraman, Karthik and Hopkins, Jarrad and Lau, John and Clayton, Philip and Tieu, Joanna and Peh, Chen Au},
  title = {Early glucocorticoid withdrawal in severe ANCA ‐associated vasculitis treated with combination cyclophosphamide and rituximab: a single‐centre case series},
  journal = {Internal Medicine Journal},
  year = {2025},
  doi = {10.1111/imj.70212}
}
Kostenlos starten →